Styliani Symbardi
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Development of antibiotic-associated diarrhea in sepsis patients is associated with dysbiosis at baseline: Data from the PROGRESS Controlled Trial.
Journal: International journal of antimicrobial agents
Published: March 25, 2026
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection.
Journal: Cell reports. Medicine
Published: March 30, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trial.
Journal: Intensive care medicine experimental
Published: January 12, 2025
Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial.
Journal: International journal of antimicrobial agents
Published: November 03, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.
Journal: Critical care (London, England)
Published: January 11, 2024
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Journal: Nature medicine
Published: October 09, 2021
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Journal: Nature medicine
Published: June 22, 2021
Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.
Journal: The Journal of antimicrobial chemotherapy
Published: August 31, 2020
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Journal: American journal of respiratory and critical care medicine
Published: August 08, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026